Market Closed -
Nasdaq
01:30:00 02/05/2024 am IST
|
5-day change
|
1st Jan Change
|
11.21
USD
|
+2.84%
|
|
+2.84%
|
-0.18%
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
502.1
|
3,419
|
5,597
|
8,784
|
-
|
-
|
Enterprise Value (EV)
1 |
502.1
|
1,568
|
5,597
|
2,482
|
3,677
|
4,360
|
P/E ratio
|
-2.6
x
|
-3.92
x
|
-5.2
x
|
2.16
x
|
-8.68
x
|
-8.72
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
61.8
x
|
91.3
x
|
13.4
x
|
52
x
|
26.5
x
|
EV / Revenue
|
-
|
28.4
x
|
91.3
x
|
3.79
x
|
21.8
x
|
13.2
x
|
EV / EBITDA
|
-
|
-1.17
x
|
-4.84
x
|
-2.31
x
|
-3.84
x
|
-6.89
x
|
EV / FCF
|
-
|
-
|
-
|
16.8
x
|
-3.33
x
|
-4.18
x
|
FCF Yield
|
-
|
-
|
-
|
5.96%
|
-30%
|
-23.9%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
51,340
|
6,92,072
|
7,58,427
|
8,05,846
|
-
|
-
|
Reference price
2 |
9.780
|
4.940
|
7.380
|
11.21
|
11.21
|
11.21
|
Announcement Date
|
01/07/21
|
28/06/22
|
28/06/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
55.29
|
61.28
|
654.6
|
168.9
|
331.4
|
EBITDA
1 |
-
|
-1,346
|
-1,156
|
-1,074
|
-958.5
|
-633
|
EBIT
1 |
-
|
-1,352
|
-1,175
|
1,605
|
-1,131
|
-1,110
|
Operating Margin
|
-
|
-2,444.82%
|
-1,917.95%
|
245.19%
|
-669.84%
|
-334.94%
|
Earnings before Tax (EBT)
1 |
-
|
-923.7
|
-1,225
|
4,170
|
-1,100
|
-1,083
|
Net income
1 |
-809.2
|
-845.3
|
-1,009
|
4,253
|
-997.9
|
-997.2
|
Net margin
|
-
|
-1,528.89%
|
-1,646.59%
|
649.74%
|
-590.8%
|
-300.88%
|
EPS
2 |
-3.760
|
-1.260
|
-1.420
|
5.182
|
-1.292
|
-1.286
|
Free Cash Flow
1 |
-
|
-
|
-
|
148
|
-1,105
|
-1,042
|
FCF margin
|
-
|
-
|
-
|
22.61%
|
-654.06%
|
-314.47%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
3.48%
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/07/21
|
28/06/22
|
28/06/23
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
13.99
|
24.34
|
9.223
|
4.319
|
12.53
|
17.05
|
27.38
|
21.62
|
37.1
|
37.14
|
31.67
|
48.34
|
34.97
|
38.65
|
43.24
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-280.8
|
-378.1
|
-228.2
|
-270.6
|
-270.9
|
-282.1
|
-240.3
|
-
|
-
|
-
|
-
|
EBIT
1 |
-684.4
|
-246
|
-266.8
|
-282.3
|
-280.8
|
-378.1
|
-234.2
|
-276.4
|
-276.5
|
5,061
|
-284.4
|
-251.5
|
-283.4
|
-297
|
-301.9
|
Operating Margin
|
-4,893.32%
|
-1,010.73%
|
-2,892.8%
|
-6,536.44%
|
-2,240.21%
|
-2,217.2%
|
-855.37%
|
-1,278.27%
|
-745.14%
|
13,626.5%
|
-897.98%
|
-520.37%
|
-810.21%
|
-768.34%
|
-698.1%
|
Earnings before Tax (EBT)
1 |
-225.2
|
-306
|
-291.5
|
-349.8
|
-313.8
|
-382.1
|
-179.2
|
-326.1
|
-327.4
|
5,098
|
-284.9
|
-231
|
-272.5
|
-286.5
|
-299.1
|
Net income
1 |
-208.5
|
-284.5
|
-270.1
|
-331.8
|
-291.6
|
-352
|
-33.62
|
-291.8
|
-304.3
|
5,096
|
-255.6
|
-209.7
|
-246.5
|
-258.6
|
-270.2
|
Net margin
|
-1,490.53%
|
-1,168.96%
|
-2,928.14%
|
-7,682.54%
|
-2,326.58%
|
-2,064.36%
|
-122.8%
|
-1,349.5%
|
-820.27%
|
13,721.55%
|
-807.17%
|
-433.84%
|
-704.94%
|
-668.98%
|
-624.72%
|
EPS
2 |
-0.3200
|
-0.4100
|
-0.3900
|
-0.4800
|
-0.4200
|
-0.4900
|
-0.0500
|
-0.3800
|
-0.4000
|
6.030
|
-0.3000
|
-0.3420
|
-0.3480
|
-0.3620
|
-0.3660
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/11/21
|
14/02/22
|
28/06/22
|
15/08/22
|
14/11/22
|
13/02/23
|
28/06/23
|
14/08/23
|
13/11/23
|
13/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,850
|
-
|
6,302
|
5,107
|
4,424
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
148
|
-1,105
|
-1,042
|
ROE (net income / shareholders' equity)
|
-
|
-48.9%
|
-
|
123%
|
-26.8%
|
-33.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-40.6%
|
95.7%
|
-21.3%
|
-25.2%
|
Assets
1 |
-
|
-
|
2,487
|
4,445
|
4,683
|
3,957
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
5.660
|
-1.010
|
-
|
Capex
1 |
-
|
17.4
|
-
|
4.29
|
5.93
|
6.28
|
Capex / Sales
|
-
|
31.54%
|
-
|
0.66%
|
3.51%
|
1.89%
|
Announcement Date
|
01/07/21
|
28/06/22
|
28/06/23
|
-
|
-
|
-
|
Last Close Price
11.21
USD Average target price
16.08
USD Spread / Average Target +43.44% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.18% | 8.78B | | +33.25% | 704B | | +28.59% | 577B | | -3.55% | 348B | | +18.16% | 327B | | +4.36% | 288B | | +14.81% | 234B | | +4.93% | 198B | | -9.78% | 194B | | -3.69% | 147B |
Other Pharmaceuticals
|